Burcon announces conditional listing on TSX

    VANCOUVER, June 2 /CNW/ - Burcon NutraScience Corporation (TSXV -BU)
("Burcon" or the "Corporation") is pleased to announce that the Toronto Stock
Exchange ("TSX") has conditionally approved the Corporation's application for
listing its common shares on the TSX. Subject to the completion of Burcon's
previously announced prospectus offering for gross proceeds in an amount
satisfactory to the TSX, Burcon expects to satisfy the listing requirements of
the TSX.

    About Burcon NutraScience

    Burcon is a leader in nutrition, health and wellness in the field of
functional, renewable plant proteins. Since 1999, Burcon has developed a
portfolio of composition, application, and process patents originating from
our core protein extraction and purification technology. We are developing the
world's first commercial canola proteins, Puratein(R) and Supertein(TM) with
unique functional and nutritional attributes, and CLARISOY(TM), a
revolutionary soy protein isolate which is 100% soluble and completely
transparent in acidic solutions. Our team of highly specialized scientists and
engineers work from our own research facility to develop and optimize
environmentally sound technologies. To-date, our patent portfolio consists of
84 issued patents in various countries, including 8 issued U.S. patents, and
well in excess of 200 pending patent applications, 55 of which are U.S. patent

    "Johann F. Tergesen"
    Johann F. Tergesen
    President and Chief Operating Officer

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as
    that term is defined in the policies of the TSX Venture Exchange) accepts
    responsibility for the adequacy or accuracy of this release.

    This press release contains forward-looking statements that involve risks
and uncertainties. These forward-looking statements relate to, among other
things, plans and timing for the introduction or enhancement of our products,
statements about future market conditions, supply and demand conditions, and
other expectations, intentions and plans contained in this press release that
are not historical fact. Our expectations regarding the prospect for future
success depend upon our ability to develop and sell products, which we do not
produce today and cannot be sold without further research and development.
When used in this press release, the words "goal", "intend", "believes",
"potential", "expects", "TSX listing" and "completion of the offering" and
similar expressions, generally identify forward-looking statements. These
statements reflect our current expectations. They are subject to a number of
risks and uncertainties. In light of the many risks and uncertainties
surrounding the development of a source of protein from canola meal, you
should understand that we cannot assure you that the forward looking
statements contained in this press release will be realized.

For further information:

For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, (604) 733-0896, (888) 408-7960 toll-free,
jcheng@burcon.ca, www.burcon.ca; AXINO AG, Sven Olsson, Investor Relations
Europe, AXINO AG, Königstrasse 26, 70173 Stuttgart, Germany, Tel. +49-711-25
35 92-30, Fax +49-711-25 35 92-33, olsson@axino.de, www.burcon.net

Organization Profile

Burcon NutraScience Corporation

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890